AQP9 has been recently demonstrated to have an important pathophysiological role in sepsis, since RG100204, a novel, potent and selective AQP9 inhibitor, reduced septic cardiomyopathy and multiple organ failure in a cecal ligation and puncture (CLP) induced murine model of polymicrobial infection [97]. This evidence concerns the gene AQP9 and infection.